Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (10)

2011

  1. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283

  2. Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 18, Núm. 5, pp. 325-330

2009

  1. Rate and timing of hepatitis c virus relapse after a successful course of pegylated interferon plus ribavirin in hiv-infected and hiv-uninfected patients

    Clinical Infectious Diseases, Vol. 49, Núm. 9, pp. 1397-1401

2003

  1. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

    AIDS, Vol. 17, Núm. 7, pp. 1023-1028

  2. Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α-2b Plus Ribavirin

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 12, pp. 1083-1089

2002

  1. Liver toxicity caused by nevirapine

    AIDS, Vol. 16, Núm. 2, pp. 290-291

2001

  1. Higher efavirenz plasma levels correlate with development of insomnia [1]

    Journal of Acquired Immune Deficiency Syndromes

1998

  1. Eficacia y tolerancia de la combinacion AZT, DDC y saquinavir en pacientes infectados por el virus de la inmunodeficiencia humana

    Revista Clinica Espanola

  2. Interacciones farmacológicas en los pacientes infectados por el virus de la inmunodeficiencia humana

    Revista Clinica Espanola, Vol. 198, Núm. 11, pp. 765-768

  3. Virological failure and adherence to antiretroviral therapy in HIV-infected patients [7]

    AIDS